NBIX
NASDAQ · Biotechnology
Neurocrine Biosciences Inc
$164.63
+4.87 (+3.05%)
Analyst Consensus
Strong Buy
37
Analysts
Very High
Coverage
Price Target
Analyst Price Target
-22.9% upside
Low Target
$104.30
Average Target
$126.93
High Target
$177.55
Current Price
$164.63
Current
$164.63
$164.63
Target
$126.93
$126.93
$104.30
$126.93 avg
$177.55
Scenario Analysis
Bear Case
$104.30
-36.6%
Low target
Base Case
$126.93
-22.9%
Avg target
Bull Case
$177.55
+7.8%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$186.12
-11.5% from high
52-Week Low
$122.14
+34.8% from low
50-Day SMA
$147.22
+11.8% vs SMA
200-Day SMA
$148.02
+11.2% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$126.93
-31.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |